DV
Dividend Vision

RCEL — Avita Medical Ltd

Avita Medical Ltd (RCEL)

Its deepest 1-year drawdown was 51.6%.

AVITA Medical is a therapeutic acute wound care company that develops and commercializes cell harvesting devices, primarily its RECELL System line for treating thermal burn wounds, full-thickness skin defects, and vitiligo, along with complementary biosynthetic and collagen-based wound matrices. The company does not currently distribute dividends. AVITA Medical serves hospitals, treatment centers, and distributors across the United States, Japan, the European Union, Australia, and the United Kingdom.

RCEL key facts

Asset type
Stock
Asset class
Equity
Inception date
03/29/2012
Last close
$7.85
Market cap
$158,192,176
Average volume
270900.0
Beta
1.858
Payout ratio
0.0
Forward P/E
10.2881
EPS
$-1.57